Navigation Links
Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
Date:6/4/2008

ment effort is driven by its proprietary plasma protein extraction technology to develop next-generation products, including surgical hemostats. Haemacure's lead product candidate, Hemaseel(R)HMN, is a fibrin sealant to enter pivotal Phase II/Phase III clinical trials during the first quarter of 2009. Haemacure's second product candidate is thrombin, a component of fibrin sealant, now in preclinical stage. Follow-on development will focus on surgical hemostats, wound healing, adhesion prevention, regenerative medecine, drug delivery and combination with biomaterials. Haemacure has identified eleven additional specialty proteins and enzymes in one if its two plasma fractions and seeks to advance these proteins and enzymes through partnerships with pharmaceutical and biotechnology companies. Haemacure operates offices in Sarasota, Florida through a wholly-owned subsidiary. The Corporation is traded under stock symbol HAE on the TSX.

Forward-looking Statements

Certain of the statements contained in this news release are forward-looking statements. Such statements, based as they are on the current expectations of management, inherently involve numerous risks and uncertainties, known and unknown. Some examples of known risks are: the impact of general economic conditions, general conditions in the biotech industry, changes in the regulatory environment in the jurisdictions in which Haemacure does business, stock market volatility, fluctuations in costs, and changes to the competitive environment due to consolidation or otherwise. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements. Haemacure disclaims any intention or obligation to update these statements.


'/>"/>
SOURCE HAEMACURE CORPORATION
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Haemacure Reports Third Quarter 2007 Results
2. Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials
3. Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec
4. Haemacure Announces Details of its Annual General and Special Meeting of Shareholders
5. Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure
6. Haemacure Reports on its annual general and special meeting of shareholders
7. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
8. Haemacure to Present at the BioFinance 2008 Conference to be held at the Toronto Marriott Eaton Centre, May 6 - 8, 2008
9. Haemacure financing receives shareholder consent - Series B Warrants are amended
10. Haemacure announces webcast of presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference
11. Haemacure to Present at Busines$ Meets Finance on May 20, 2008 at the Montreal Sheraton Centre
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... Flagstaff, AZ (PRWEB) August 30, 2014 Jake ... High School while in the Back2Basics Outdoor Adventures ... want to finish high school so I can actually start ... need English and math, and I'm done.” , He has ... the initial Back2Basics program. Most clients choose to continue on ...
(Date:8/30/2014)... Ohio (PRWEB) August 30, 2014 As 500 ... birth defect when give to pregnant mothers, Wright & Schulte ... Judge Cynthia M. Rufe. The remand in the ... representative of 18 states and are involved in one ... them to have their Zoloft birth defect lawsuit sent back ...
(Date:8/30/2014)... GA (PRWEB) August 30, 2014 The ... Open Challenge and K.Warrior Search on November 8th, 2014 ... 20 years, these events have introduced many notorious and ... as Strike-Force, IWF and the UFC. , Among ... numerous fighters leave its doors armed with the virtues ...
(Date:8/30/2014)... Saturday 30 August 2014: The first comprehensive ESC Guidelines ... at ESC Congress 2014 by Task Force Chairpersons Professor ... The "2014 ESC Guidelines on the diagnosis and treatment ... European Heart Journal (1) and on the ... were published in 2001 but they were restricted to ...
(Date:8/29/2014)... The Enchant Him review that was recently ... is a system that promises to teach ladies how to ... Carrie Engel, who actually is a popular relationship expert and ... the best advices out there, Carrie worked at this program ... new program is a simple to use step by step ...
Breaking Medicine News(10 mins):Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 2Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 3Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 4Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 5Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 2Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 3Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 4Health News:First comprehensive ESC Guidelines on aortic diseases published 2Health News:First comprehensive ESC Guidelines on aortic diseases published 3Health News:Enchant Him Review Reveals Unique Relationship Tips for Women 2
... together explained that they have identified the gene that ... caused by an abnormal build up of iron in ... the PLA2G6 gene, whose mutated forms trigger several genetic ... could also shed light on the nerve cell degeneration ...
... Institute finds children who have habit of eating foods high ... ,Therefore, TSI warned parents to be cautious about ... the market, which was concluded after surveying about 270 processed ... was evident that children’s consuming food with highest fat content ...
... antidepressants to the REM Sleep Behavior Disorder (RBD). The ... causes //the onset of this disorder at a younger ... where patients act out their dreams, which are often ... medicine specialist, neurologist and study investigator. This acting out ...
The Indian Institute of Management, Ahmedabad (IIMA) here Monday signed a memorandum of understanding (MoU) with the US-based Duke Corporate Education //CE to offer customised corporate education prog...
... More than 25 children have died of suspected encephalitis and ... Muzaffarpur district for the past few days //. ... the spread of the killer disease. The children reported sudden ... bouts of unconsciousness and convulsion leading to their death. ...
... childbirth to ease the pain during labor. But such epidurals ... National Patient Safety Agency (NPSA) in response has issued warnings ... that about 200 errors have been committed due a period ... be administered at the base of the spine, but in ...
Cached Medicine News:Health News:Rare Nerve Disease Causing Gene Identified 2
(Date:8/29/2014)... 2014 , Industry professionals ... inaugural Tweetchat taking place in real-time at CPhI ... by UBM Live , announces the launch ... first of its kind global industry-wide Tweetchat for ... chain, aimed to stimulate conversations on key industry ...
(Date:8/28/2014)... YORK, Aug. 28, 2014 Reportlinker.com announces ... in its catalogue: North America Aesthetic ... http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html ... Outlook to 2020 Summary GlobalData,s new ... Market Outlook to 2020", provides key market data ...
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces ... is available in its catalogue: ... Services Industry (U.S.): Analytics, Extensive Financial ... 2021, NAIC 541380 ... Testing Laboratories, Safety and Compliance Services ...
Breaking Medicine Technology:CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 2Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 4Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 6
... , MORRISTOWN, N.J., Dec. 8 In consultation with the ... has begun a voluntary recall of a single product lot ... Cold Formula Liquid Gels. Bayer initiated the recall after ... certain packages within the lot (less than 4 percent) were ...
... , WILMINGTON, Del., Dec. 8 AstraZeneca ... in the company,s Medicare Part D prescription savings program will ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) , Prescriptions ... offices under the changes to the AZ&Me(TM) Prescription Savings program ...
Cached Medicine Technology:Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2AstraZeneca Medicare Part D Patient Assistance Program No Longer Requires Co-Pays 2
Cushing bayonet....
Blunt, with attached cable for Valleylab and other brands generators....
Pointed, 12 cm long....
Angulated, blunt tips....
Medicine Products: